Literature DB >> 29144207

Exploring physical activity behaviour - needs for and interest in a technology-delivered, home-based exercise programme among patients with intermittent claudication.

Nils Cornelis1, Roselien Buys1,2, Inge Fourneau2, Tijl Dewit1, Véronique Cornelissen1.   

Abstract

BACKGROUND: Supervised walking is a first line therapy in peripheral arterial disease (PAD) with complaints of intermittent claudication. However, uptake of supervised programmes is low. Home-based exercise seems an appealing alternative; especially since technological advances, such as tele-coaching and tele-monitoring, may facilitate the process and support patients when adopting a physically active lifestyle. To guide the development of such an intervention, it is important to identify barriers of physical activity and the needs and interests for technology-enabled exercise in this patient group. PATIENTS AND METHODS: PAD patients were recruited at the vascular centre of UZ Leuven (Belgium). A questionnaire assessing PA (SF-International Physical Activity Questionnaire), barriers to PA, and interest in technology-supported exercise (Technology Usage Questionnaire) was completed. Descriptive and correlation analyses were performed.
RESULTS: Ninety-nine patients (76 men; mean age 69 years) completed the survey. Physical activity levels were low in 48 %, moderate in 29 %, and high in 23 %. Intermittent claudication itself is the most important barrier for enhanced PA, with most patients reporting pain (93 %), need for rest (92 %), and obstacles worsening their pain (74 %) as barriers. A total of 93 % participants owned a mobile phone; 76 % had Internet access. Eighty-seven reported the need for an exercise programme, with 67 % showing interest in tele-coaching to support exercise. If technology was available, three-quarter stated they would be interested in home-based tele-coaching using the Internet (preferably e-mails, 86 %); 50 % via mobile phone, 87 % preferred text messages. Both were inversely related to age (rpb = 0.363 and rpb = 0.255, p < 0.05). Acquaintance with elastic bands or gaming platforms was moderate (55 and 49 %, respectively), but patients were interested in using them as alternatives (84 and 42 %). Interest in platforms was age-dependent (rs = -0.508, p < 0.01).
CONCLUSIONS: PAD patients show significant interest in technology-delivered exercise, offering opportunities to develop a guided home-based exercise programme.

Entities:  

Keywords:  Peripheral arterial disease; eHealth; intermittent claudication; lifestyle modification; physical activity; rehabilitation

Mesh:

Year:  2017        PMID: 29144207     DOI: 10.1024/0301-1526/a000654

Source DB:  PubMed          Journal:  Vasa        ISSN: 0301-1526            Impact factor:   1.961


  4 in total

1.  Satisfaction and Acceptability of Telemonitored Home-Based Exercise in Patients With Intermittent Claudication: Pragmatic Observational Pilot Study.

Authors:  Nils Cornelis; Roselien Buys; Tijl Dewit; Dries Benoit; Jomme Claes; Inge Fourneau; Véronique Cornelissen
Journal:  JMIR Rehabil Assist Technol       Date:  2021-03-22

2.  Effects of exercise prescribed at different levels of claudication pain on walking performance in patients with intermittent claudication: a protocol for a randomised controlled trial.

Authors:  Stefan T Birkett; Jonathan Sinclair; Sally A Seed; Sean Pymer; Edward Caldow; Lee Ingle; Amy E Harwood; Anselm Egun
Journal:  Ther Adv Cardiovasc Dis       Date:  2022 Jan-Dec

3.  Comparing the Effectiveness of a Wearable Activity Tracker in Addition to Counseling and Counseling Only to Reinforce Leisure-Time Physical Activity among Breast Cancer Patients: A Randomized Controlled Trial.

Authors:  Sunga Kong; Jae Kyung Lee; Danbee Kang; Nayeon Kim; Young Mog Shim; Won Park; Dooho Choi; Juhee Cho
Journal:  Cancers (Basel)       Date:  2021-05-30       Impact factor: 6.639

4.  Barriers and enablers to walking in individuals with intermittent claudication: A systematic review to conceptualize a relevant and patient-centered program.

Authors:  Ukachukwu Abaraogu; Elochukwu Ezenwankwo; Philippa Dall; Garry Tew; Wesley Stuart; Julie Brittenden; Chris Seenan
Journal:  PLoS One       Date:  2018-07-26       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.